Skip to main content
SpringerLink
Log in

Psychopharmacological Treatment

  • Chapter
  • First Online:
Handbook of Recovery in Inpatient Psychiatry

Part of the book series: Evidence-Based Practices in Behavioral Health ((EBPBH))

  • 1812 Accesses

Abstract

This chapter discusses the role of pharmacotherapy in assisting persons on their personal journey toward obtaining recovery. Medications have been clearly shown to be effective with reduction or elimination of symptoms, which is viewed as an important element of this process for many people. In addition, there is evidence that ongoing treatment with psychotropic medications can improve outcomes, such as time to relapse and hospitalization rates. There are times when care recipients do not have decisional capacity, but as soon as safety allows they must be involved in decisions surrounding appropriate, individualized pharmacotherapy. This chapter reviews the basic tenets of recovery-oriented pharmacotherapy that involve shared decisions about symptom- or diagnosis-specific evidenced-based care and amelioration of possible adverse effects. There are many factors that affect a person’s response and sensitivity to medication including gender, age, race, genetic make-up, and health status, which must be taken into account when making recommendations about management. There are also several, very debilitating adverse effects of psychotropic medications such as movement disorders and metabolic derangements, which can negatively affect a person’s health status and therefore quality of life. All of these issues can serve as barriers to a productive partnership in the development of pharmacological treatment regimens. Finally, these and other impediments must be addressed as people are transitioned from hospitals to fuller lives in the community.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alexopoulos, G. S., Borson, S., Cuthbert, B. N., Devanand, D. P., Mulsant, B. H., Olin, J. T., & Oslin, D. W. (2002). Assessment of late life depression. Biological Psychiatry, 52(3), 164–174.

    Article  PubMed  Google Scholar 

  • American Psychiatric Association. (2010). Practice guideline for the treatment of patients with major depressive disorder (3rd ed.). Washington, DC: American Psychiatric Publishing Inc.

    Google Scholar 

  • Appelbaum, P. S. (1988). The right to refuse treatment with antipsychotic medications: Retrospect and prospect. American Journal of Psychiatry, 145(4), 413–419.

    Article  PubMed  Google Scholar 

  • Austin, M. P., Mitchell, P., & Goodwin, G. M. (2001). Cognitive deficits in depression: Possible implications for functional neuropathology. British Journal of Psychiatry, 178, 200–206.

    Article  PubMed  Google Scholar 

  • Barkhof, E., Meijer, C. J., de Sonneville, L. M., Linszen, D. H., & de Haan, L. (2012). Interventions to improve adherence to antipsychotic medication in patients with schizophrenia—A review of the past decade. European Psychiatry, 27(1), 9–18.

    Article  PubMed  Google Scholar 

  • Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., & Moller, H. J. (2013). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders. World Journal of Biological Psychiatry, 14(5), 334–385.

    Google Scholar 

  • Bellack, A. S. (2006). Scientific and consumer models of recovery in schizophrenia: Concordance, contrasts, and implications. Schizophrenia Bulletin, 32(3), 432–442.

    Article  PubMed  PubMed Central  Google Scholar 

  • Besag, F. M., & Berry, D. (2006). Interactions between antiepileptic and antipsychotic drugs. Drug Safety, 29(2), 95–118.

    Article  PubMed  Google Scholar 

  • Bizub, A. L. (2013). A hard pill to swallow: Medication, empathy, and the value of collaborative recovery. Community Mental Health Journal, 49(3), 338–343.

    Article  PubMed  Google Scholar 

  • Brandl, E. J., Kennedy, J. L., & Muller, D. J. (2014). Pharmacogenetics of antipsychotics. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 59(2), 76–88.

    PubMed  PubMed Central  Google Scholar 

  • Campanelli, C. M. (2012). American geriatrics society updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 60(4), 616–631.

    Article  PubMed Central  Google Scholar 

  • Campbell, L. A., & Kisely, S. R. (2009). Advance treatment directives for people with severe mental illness. Cochrane Database Systematic Reviews, (1), CD005963.

    Google Scholar 

  • Cerovecki, A., Musil, R., Klimke, A., Seemuller, F., Haen, E., Schennach, R., & Riedel, M. (2013). Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: Theoretical background and practical recommendations. CNS Drugs, 27(7), 545–572.

    Article  PubMed  Google Scholar 

  • Charney, D. S., Reynolds, C. F., 3rd, Lewis, L., Lebowitz, B. D., Sunderland, T., & Alexopoulos, G. S. (2003). Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Archives of General Psychiatry, 60(7), 664–672.

    Google Scholar 

  • Clark, N. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27(2), 596–601.

    Article  Google Scholar 

  • David, G. (2010). The pharmacology of aging. In H. Fillit, K. Rockwood, K. W. Woodhouse, & J. C. Brocklehurst (Eds.), Brocklehurst’s textbook of geriatric medicine and gerontology (7th ed., pp. 138–144). Philadelphia, PA: Saunders/Elsevier.

    Chapter  Google Scholar 

  • Davidson, L., O’Connell, M., Tondora, J., Styron, T., & Kangas, K. (2006). The top ten concerns about recovery encountered in mental health system transformation. Psychiatric Services, 57(5), 640–645.

    Article  PubMed  Google Scholar 

  • De Hert, M., Correll, C. U., Bobes, J., Cetkovich-Bakmas, M., Cohen, D., Asai, I., & Leucht, S. (2011a). Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10(1), 52–77.

    Article  Google Scholar 

  • De Hert, M., Hudyana, H., Dockx, L., Bernagie, C., Sweers, K., Tack, J., & Peuskens, J. (2011b). Second-generation antipsychotics and constipation: A review of the literature. European Psychiatry, 26(1), 34–44.

    Article  PubMed  Google Scholar 

  • Deegan, P. E. (2007). The lived experience of using psychiatric medication in the recovery process and a shared decision-making program to support it. Psychiatric Rehabilitation Journal, 31(1), 62–69.

    Article  PubMed  Google Scholar 

  • Deegan, P. E., & Drake, R. E. (2006). Shared decision making and medication management in the recovery process. Psychiatric Services, 57(11), 1636–1639. doi:10.1176/appi.ps.57.11.1636

    Google Scholar 

  • Dibonaventura, M., Gabriel, S., Dupclay, L., Gupta, S., & Kim, E. (2012). A patient perspective of the impact of medication side effects on adherence: Results of a cross-sectional nationwide survey of patients with schizophrenia. BMC Psychiatry, 12, 20.

    Article  PubMed  PubMed Central  Google Scholar 

  • Dickey, B., Normand, S. L., Weiss, R. D., Drake, R. E., & Azeni, H. (2002). Medical morbidity, mental illness, and substance use disorders. Psychiatric Services, 53(7), 861–867.

    Article  PubMed  Google Scholar 

  • Dolder, C. R., Lacro, J. P., Leckband, S., & Jeste, D. V. (2003). Interventions to improve antipsychotic medication adherence: Review of recent literature. Journal of Clinical Psychopharmacology, 23(4), 389–399.

    Article  PubMed  Google Scholar 

  • Drake, R. E., Deegan, P. E., & Rapp, C. (2010). The promise of shared decision making in mental health. Psychiatric Rehabilitation Journal, 34(1), 7–13.

    Article  PubMed  Google Scholar 

  • Drake, R. E., Goldman, H. H., Leff, H. S., Lehman, A. F., Dixon, L., Mueser, K. T., et al. (2001). Implementing evidence-based practices in routine mental health service settings. Psychiatric Services, 52(2), 179–182.

    Google Scholar 

  • Drane, J. F. (1984). Competency to give an informed consent. A model for making clinical assessments. Journal of the American Medical Association, 252(7), 925–927.

    Article  PubMed  Google Scholar 

  • Fabbri, C., Porcelli, S., & Serretti, A. (2014). From pharmacogenetics to pharmacogenomics: The way toward the personalization of antidepressant treatment. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 59(2), 62–75.

    PubMed  PubMed Central  Google Scholar 

  • Fava, G., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015). Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: A systematic review. Psychotherapy and Psychosomatics, 84, 72–81.

    Article  PubMed  Google Scholar 

  • Fenton, W. S., Blyler, C. R., & Heinssen, R. K. (1997). Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophrenia Bulletin, 23(4), 637–651.

    Article  PubMed  Google Scholar 

  • Ferguson, J. M. (2001). SSRI antidepressant medications: Adverse effects and tolerability. Primary Care Companion to the Journal of Clinical Psychiatry, 3(1), 22–27.

    Article  PubMed  PubMed Central  Google Scholar 

  • Fisher, D. B., & Ahern, L. (2002). Evidence-based practices and recovery. Psychiatric Services, 53(5), 632–634.

    Article  PubMed  Google Scholar 

  • Frese, F. J, 3rd, Stanley, J., Kress, K., & Vogel-Scibilia, S. (2001). Integrating evidence-based practices and the recovery model. Psychiatric Services, 52(11), 1462–1468.

    Article  PubMed  Google Scholar 

  • Gandhi, M., Aweeka, F., Greenblatt, R. M., & Blaschke, T. F. (2004). Sex differences in pharmacokinetics and pharmacodynamics. Annual Review of Pharmacology and Toxicology, 44, 499–523.

    Article  PubMed  Google Scholar 

  • Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., et al. (2003). Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review. Lancet, 361(9358), 653–661.

    Google Scholar 

  • Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., et al. (2012). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World Journal of Biological Psychiatry, 13(5), 318-378.

    Google Scholar 

  • Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., et al. (2013). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World Journal of Biological Psychiatry, 14(1), 2–44.

    Google Scholar 

  • Henderson, H. (2004). From depths of despair to heights of recovery. Psychiatric Rehabilitation Journal, 28(1), 83–87.

    Article  PubMed  Google Scholar 

  • Houghton, J. F. (1982). First person account: Maintaining mental health in a turbulent world. Schizophrenia Bulletin, 8(3), 548–553.

    Article  PubMed  Google Scholar 

  • Karow, A., Czekalla, J., Dittmann, R. W., Schacht, A., Wagner, T., Lambert, M., et al. (2007). Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. Journal of Clinical Psychiatry, 68(1), 75–80.

    Google Scholar 

  • Kato, M., & Serretti, A. (2010). Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Molecular Psychiatry, 15(5), 473–500.

    Article  PubMed  Google Scholar 

  • Kaymaz, N., van Os, J., Loonen, A. J., & Nolen, W. A. (2008). Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: A meta-analysis of placebo-controlled randomized trials. Journal of Clinical Psychiatry, 69(9), 1423–1436.

    Article  PubMed  Google Scholar 

  • Kingsbury, S. J., Yi, D., & Simpson, G. M. (2001). Psychopharmacology: Rational and irrational polypharmacy. Psychiatric Services, 52(8), 1033–1036.

    Article  PubMed  Google Scholar 

  • Krishnan, K. R., Delong, M., Kraemer, H., Carney, R., Spiegel, D., Gordon, C., et al. (2002). Comorbidity of depression with other medical diseases in the elderly. Biological Psychiatry, 52(6), 559–588.

    Google Scholar 

  • Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. Journal of Clinical Psychiatry, 63(10), 892–909.

    Article  PubMed  Google Scholar 

  • Lehman, A. F., & Steinwachs, D. M. (1998). Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophrenia Bulletin, 24(1), 11–32.

    Article  PubMed  Google Scholar 

  • Liberman, R. P. (2008). Illness managment. In R. P. Liberman (Ed.), Recovery from disability (pp. 100–119). Washington, DC: American Psychiatric Publishing, Inc.

    Google Scholar 

  • Liberman, R. P., & Kopelowicz, A. (2005). Recovery from schizophrenia: A concept in search of research. Psychiatric Services, 56(6), 735–742.

    Article  PubMed  Google Scholar 

  • Lunt, A. (2002). A theory of recovery. Journal of Psychosocial Nursing and Mental Health Services, 40(12), 32–39.

    PubMed  Google Scholar 

  • Malhotra, A. K., Murphy, G. M, Jr., & Kennedy, J. L. (2004). Pharmacogenetics of psychotropic drug response. American Journal of Psychiatry, 161(5), 780–796.

    Article  PubMed  Google Scholar 

  • Mangoni, A. A., & Jackson, S. H. (2004). Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. British Journal of Clinical Pharmacology, 57(1), 6–14.

    Article  PubMed  PubMed Central  Google Scholar 

  • Martinez-Aran, A., Vieta, E., Reinares, M., Colom, F., Torrent, C., Sanchez-Moreno, J., et al. (2004). Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. American Journal of Psychiatry, 161(2), 262–270.

    Google Scholar 

  • Mellman, T. A., Miller, A. L., Weissman, E. M., Crismon, M. L., Essock, S. M., & Marder, S. R. (2001). Evidence-based pharmacologic treatment for people with severe mental illness: A focus on guidelines and algorithms. Psychiatric Services, 52(5), 619–625.

    Article  PubMed  Google Scholar 

  • Menninger, J. A. (2001). Involuntary treatment: Hospitalization and medications. In J. L. Jacobson & M. Alan (Eds.), Psychiatric secrets (2nd ed., pp. 477–484). Philadelphia, PA: Harley and Belfus Inc.

    Google Scholar 

  • Minzenberg, M. J., Poole, J. H., Benton, C., & Vinogradov, S. (2004). Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. American Journal of Psychiatry, 161(1), 116–124.

    Article  PubMed  Google Scholar 

  • Moller, H. J., & Nasrallah, H. A. (2003). Treatment of bipolar disorder. Journal of Clinical Psychiatry, 64(Suppl 6), 9–17.

    PubMed  Google Scholar 

  • Moore, T. A., Buchanan, R. W., Buckley, P. F., Chiles, J. A., Conley, R. R., Crismon, M. L., et al. (2007). The Texas medication algorithm project antipsychotic algorithm for schizophrenia: 2006 update. Journal of Clinical Psychiatry, 68(11), 1751–1762.

    Google Scholar 

  • Nasrallah, H. A., Targum, S. D., Tandon, R., McCombs, J. S., & Ross, R. (2005). Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psychiatric Services, 56(3), 273–282.

    Article  PubMed  Google Scholar 

  • Newcomer, J. W., Weiden, P. J., & Buchanan, R. W. (2013). Switching antipsychotic medications to reduce adverse event burden in schizophrenia: establishing evidence-based practice. Journal of Clinical Psychiatry, 74(11), 1108–1120.

    Article  PubMed  Google Scholar 

  • Nicaise, P., Lorant, V., & Dubois, V. (2013). Psychiatric Advance Directives as a complex and multistage intervention: A realist systematic review. Health Social Care Community, 21(1), 1–14.

    Article  Google Scholar 

  • Noordsy, D. L., Torrey, W. C., Mead, S., Brunette, M., Potenza, D., & Copeland, M. E. (2000). Recovery-oriented psychopharmacology: Redefining the goals of antipsychotic treatment. Journal of Clinical Psychiatry, 61(Suppl 3), 22–29.

    PubMed  Google Scholar 

  • Noordsy, D. L., Torrey, W., Mueser, K., Mead, S., O’Keefe, C., & Fox, L. (2002). Recovery from severe mental illness: An interpersonal and functional outcome definition. International Review of Psychiatry, 14, 318–326.

    Article  Google Scholar 

  • O’Leary, D. S., Flaum, M., Kesler, M. L., Flashman, L. A., Arndt, S., & Andreasen, N. C. (2000). Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 12(1), 4–15.

    Article  PubMed  Google Scholar 

  • O’Neal, J. M. (1984). First person account: Finding myself and loving it. Schizophrenia Bulletin, 10(1), 109–110.

    Article  PubMed  Google Scholar 

  • Ozbilen, M., & Adams, C. E. (2009). Systematic overview of Cochrane reviews for anticholinergic effects of antipsychotic drugs. Journal of Clinical Psychopharmacology, 29(2), 141–146.

    Article  PubMed  Google Scholar 

  • Paquette, M., & Navarro, T. (2005). Lives recovered. Perspectives in Psychiatric Care, 41(3), 95–96.

    Article  PubMed  Google Scholar 

  • Pearlstein, T. (2013). Use of psychotropic medication during pregnancy and the postpartum period. Womens Health (Lond Engl), 9(6), 605–615.

    Article  Google Scholar 

  • Piat, M., Sabetti, J., Couture, A., Sylvestre, J., Provencher, H., Botschner, J., et al. (2009). What does recovery mean for me? Perspectives of Canadian mental health consumers. Psychiatric Rehabilitation Journal, 32(3), 199–207.

    Google Scholar 

  • Pollock, B., Forsyth, C., & Bies, R. (2009). The critical role of clinical pharmacology in geriatric psychopharmacology. Clinical Pharmacology and Therapeutics, 85(1), 89–93.

    Article  PubMed  Google Scholar 

  • Resnick, S. G., Rosenheck, R. A., & Lehman, A. F. (2004). An exploratory analysis of correlates of recovery. Psychiatric Services, 55(5), 540–547.

    Article  PubMed  Google Scholar 

  • Rossotto, E., Wirshing, D. A., & Liberman, R. P. (2004). Rehab rounds: Enhancing treatment adherence among persons with schizophrenia by teaching community reintegration skills. Psychiatric Services, 55(1), 26–27.

    Article  PubMed  Google Scholar 

  • Sachs, G. S., Printz, D. J., Kahn, D. A., Carpenter, D., & Docherty, J. P. (2000). The expert consensus guideline series: Medication treatment of bipolar disorder 2000. Postgraduate Medicine, Spec No, 1–104.

    Google Scholar 

  • Sachs, G. S., & Rush, A. J. (2003). Response, remission, and recovery in bipolar disorders: What are the realistic treatment goals? Journal of Clinical Psychiatry, 64(Suppl 6), 18–22.

    PubMed  Google Scholar 

  • Sowers, W., & Quality Management Committee of the American Association of Community Psychiatrists. (2005). Transforming systems of care: The American Association of Community Psychiatrists Guidelines for Recovery Oriented Services. Community Mental Health Journal, 41(6), 757–774.

    Google Scholar 

  • Spina, E., Scordo, M. G., & D’Arrigo, C. (2003). Metabolic drug interactions with new psychotropic agents. Fundamental & Clinical Pharmacology, 17(5), 517–538.

    Article  Google Scholar 

  • Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications. Chapter 2: Transporters, receptors, and enzymes as targets of psychopharmacological drug action. Cambridge: Cambridge University Press.

    Google Scholar 

  • Stahl, S. M., Lee-Zimmerman, C., Cartwright, S., & Morrissette, D. A. (2013). Serotonergic drugs for depression and beyond. Current Drug Targets, 14(5), 578–585.

    Article  PubMed  Google Scholar 

  • Svedberg, B., Backenroth-Ohsako, G., & Lutzen, K. (2003). On the path to recovery: patients’ experiences of treatment with long-acting injections of antipsychotic medication. International Journal of Mental Health Nursing, 12(2), 110–118.

    Article  PubMed  Google Scholar 

  • Tandon, R., Targum, S. D., Nasrallah, H. A., Ross, R., & Treatment Effectiveness in Schizophrenia Consortium. (2006). Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. Journal of Psychiatric Practice, 12(6), 348–363.

    Google Scholar 

  • Tanenbaum, S. J. (2008). Perspectives on evidence-based practice from consumers in the US public mental health system. Journal of Evaluation in Clinical Practice, 14(5), 699–706.

    Article  PubMed  Google Scholar 

  • Torrey, W. C., Drake, R. E., Dixon, L., Burns, B. J., Flynn, L., Rush, A. J., et al. (2001). Implementing evidence-based practices for persons with severe mental illnesses. Psychiatric Services, 52(1), 45–50.

    Google Scholar 

  • U.S. National Library of Medicine. (2015). Polymorphism. National Institute of Helath Retrieved from http://ghr.nlm.nih.gov/glossary=polymorphism

  • Watanabe-Galloway, S., & Zhang, W. (2007). Analysis of U.S. trends in discharges from general hospitals for episodes of serious mental illness, 1995–2002. Psychiatric Services, 58(4), 496–502.

    Article  PubMed  Google Scholar 

  • Weiden, P. J., Preskorn, S. H., Fahnestock, P. A., Carpenter, D., Ross, R., Docherty, J. P., et al. (2007). Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: A Roadmap. Journal of Clinical Psychiatry, 68 Suppl 7, 1–48.

    Google Scholar 

  • Windell, D. L., Norman, R., Lal, S., & Malla, A. (2015). Subjective experiences of illness recovery in individuals treated for first-episode psychosis. Social Psychiatry and Psychiatric Epidemiology, 50(7), 1069–1077.

    Article  PubMed  Google Scholar 

  • Windell, D., Norman, R., & Malla, A. K. (2012). The personal meaning of recovery among individuals treated for a first episode of psychosis. Psychiatric Services, 63(6), 548–553.

    Article  PubMed  Google Scholar 

  • Wirshing, D. A., Wirshing, W. C., Marder, S. R., Liberman, R. P., & Mintz, J. (1998). Informed consent: Assessment of comprehension. American Journal of Psychiatry, 155(11), 1508–1511.

    Article  PubMed  Google Scholar 

  • Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., et al. (2013). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2013. Bipolar Disord, 15(1), 1–44.

    Google Scholar 

  • Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002). Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159(10), 1653–1664.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, 997 St., Sebastian Way, Augusta, GA, USA

    Scott Van Sant

Authors
  1. Scott Van Sant
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Scott Van Sant .

Editor information

Editors and Affiliations

  1. Department of Psychiatry and Health Behavior, Augusta University Medical College of Georgia, Augusta, Georgia, USA

    Nirbhay N. Singh

  2. Virginia Department of Behavioral Health and Developmental Services , Richmond, Virginia, USA

    Jack W. Barber

  3. Medical College of Georgia, Augusta University Medical College of Georgia, Augusta, Georgia, USA

    Scott Van Sant

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Van Sant, S. (2016). Psychopharmacological Treatment. In: Singh, N., Barber, J., Van Sant, S. (eds) Handbook of Recovery in Inpatient Psychiatry . Evidence-Based Practices in Behavioral Health. Springer, Cham. https://doi.org/10.1007/978-3-319-40537-7_7

Download citation

Publish with us

Policies and ethics

Search

Navigation